Health Conditions A-Z Lung Disorders Asthma Eosinophilic Asthma By Lindsay Curtis Lindsay Curtis Lindsay Curtis is a freelance health & medical writer in South Florida. Prior to becoming a freelancer, she worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of Nursing. health's editorial guidelines Published on May 19, 2024 Medically reviewed by Daniel More, MD Medically reviewed by Daniel More, MD Daniel More, MD, FAAAAI, FACAAI, FACP, is a board-certified allergist and former clinical immunologist at Allergy Partners of the Central California Coast. learn more In This Article View All In This Article Symptoms Causes Diagnosis Treatment Prevention Related Conditions Management FAQs Close MixMedia / Getty Images Eosinophilic asthma (also known as e-asthma or eos asthma) is a severe form of asthma that causes high levels of eosinophils in the lung tissue, blood, and mucus. Eosinophils are a type of immune system cell that typically help your body fight infections. Too many of these cells can cause inflammation in your airways and worsen asthma symptoms. Eos asthma typically develops in adulthood, though it can also affect children. While the exact cause of eos asthma remains under investigation, genetic and environmental factors likely play a role in its development. This type of asthma doesn't respond to traditional treatments, so other management techniques are necessary. Targeted therapies, such as biologics, are essential for managing symptoms and preventing asthma attacks and other complications of eos asthma. Eosinophilic Asthma Symptoms People with eosinophilic asthma experience classic asthma symptoms, though they tend to be more persistent and severe than other asthma types. However, this type of asthma also causes inflammation that can narrow the airways and decrease your lung function—meaning, your lungs can't hold as much oxygen as they normally would. That said, common symptoms associated with this type of asthma include: Wheezing: A high-pitched whistling sound when breathing Coughing: A persistent, dry cough that may worsen at night or with exercise Shortness of breath: Difficulty catching your breath Chest pain: A feeling of tightness or pressure in the chest, making breathing uncomfortable Chronic rhinosinusitis: Chronic inflammation and swelling of the sinuses, which can cause nasal drainage, nasal blockage, facial pressure or pain, and a decreased sense of smell Nasal polyps: Soft growths that develop on the lining of the sinuses or nose, causing stuffiness, runny nose, loss of smell or taste, sneezing, and snoring Difficulty sleeping: Worsening symptoms at night, leading to difficulty falling or staying asleep Fatigue: Feeling tired or lethargic in the daytime due to disrupted sleep or difficulty breathing Exercise intolerance: Difficulty engaging in physical activity due to experiencing asthma symptoms during exercise Frequent respiratory infections: Impaired lung function can increase the risk of developing respiratory infections (like the common cold) Because high levels of eosinophils cause chronic airway inflammation, people with eos asthma are at a higher risk of experiencing asthma attacks—which are periods when asthma symptoms worsen. If you develop an asthma attack, common symptoms include: Coughing Increased wheezing Chest pain or feeling as though a heavy weight is sitting on your chest Difficulty catching your breath, as if you are sucking air through a straw Gasping for air Retractions, which occur when your ribs pull in with each breath Neck pain as a result of your muscles tightening if you're having trouble breathing strain to breathe Causes Eosinophilic asthma develops when abnormally high levels of eosinophils cause inflammation in the entire respiratory tract, from the sinuses to the small airways in the lungs. Eosinophils are white blood cells that play an important role in the immune system, helping your body release inflammatory chemicals that fight infections. An overactive immune response can increase eosinophil production, causing inflammation that narrows the airways, increases mucus production, and leads to hallmark asthma symptoms. Over time, inflammation can damage the airways and lung tissue, worsening asthma symptoms. Researchers don’t know exactly what causes high levels of eosinophils and eosinophilic asthma, but genetic and environmental factors likely play a role. Genetics Studies about how genetics may be associated with eosinophilic asthma are ongoing. However, researchers have discovered some inherited gene mutations (changes) that may increase your risk of developing this condition. Changes in genes that regulate the production and function of eosinophils may increase eosinophil counts in the blood and promote the buildup and activation of eosinophils in the airways. This can lead to inflammation and an increased risk of eosinophilic asthma. Environmental Triggers Some people with eosinophilic asthma also have allergic conditions, such as hay fever, eczema, or food allergies. This doesn't apply to everyone who has asthma. However, if you do experience allergies, the following environmental factors can trigger or worsen eos asthma symptoms: Pollen Pet dander Dust mites Mold spores Lung irritants, like smoke or cleaning chemicals Strenuous exercise Respiratory illnesses (e.g., the common cold, influenza) Extreme weather Stress Risk Factors While genetics and environmental factors can play a role in the development of eos asthma, other factors can also increase your risk of this condition. Consider the following: Being 35-50 years oldHaving a personal or family history of asthma or other allergic conditionsSmoking tobacco Diagnosis If you have severe asthma or your asthma symptoms do not improve with standard treatments, your healthcare provider may order tests to determine whether you have eosinophilic asthma. During your appointment, your provider will consider your symptoms, medical history, and test results to provide an accurate diagnosis. They can also order additional tests to confirm a diagnosis, including: Blood test: Blood tests measure your eosinophil count—the amount of eosinophils circulating in your blood. People with eosinophilic asthma have an eosinophil count of 150 cells or more per microliter of blood (cells/μl). Other types of asthma can also cause elevated eosinophil counts, so your healthcare provider will consider your symptoms and other test results. Sputum test: The provider collects a sample of coughed-up mucus (sputum) and examines it under a microscope to measure eosinophil cells in the sample. If you cannot bring up mucus when coughing, your provider may ask you to breathe in a saline solution through a nebulizer. In people with eosinophilic asthma, more than 2% of the cells within sputum will be eosinophils. Bronchial biopsy: A pulmonologist (a doctor specializing in lung diseases) will insert a thin tube called a bronchoscope into your nose or mouth to access your lungs. They will collect a sample of tissue or fluid and view it under the microscope to look for eosinophils and signs of inflammation. Eosinophilic Asthma Treatment If you receive a diagnosis for eos asthma, your healthcare provider will help you develop a treatment plan that meets your needs. The goal of treatment is to reduce eosinophils in the airways, control inflammation, improve asthma symptoms, and reduce the frequency and severity of asthma attacks. Most people with eosinophilic asthma respond well to traditional asthma treatments but require some biologic medications directed against eosinophils or cytokines that regulate eosinophil growth and development. Standard Asthma Treatments First-line treatments for eos asthma are the same medications healthcare providers use to treat other types of asthma. These include: Bronchodilators: Inhaled medicines that relax the muscles around the airways to open them and relieve symptoms like coughing, chest tightness, and wheezing. For example, short-acting beta-2 agonists (SABAs) provide quick relief when symptoms worsen, while long-acting beta-2 agonists (LABAs) help keep airways open for longer periods. Muscarinic antagonists are other bronchodilators that can be short-acting (SAMAs) or long-acting (LAMAs). Corticosteroids: Powerful anti-inflammatory drugs that help reduce airway inflammation. Leukotriene modifiers: Oral medications that block the action of leukotrienes—inflammatory immune chemicals that are involved in your body’s immune response to allergens. These medicines help reduce airway swelling in people with eos asthma and allergies. Biologics Healthcare providers prescribe biologic medications for people with eos asthma when traditional asthma treatments are ineffective. Your healthcare provider may prescribe biologic drugs via subcutaneous injections (under the skin) or intravenous administration (through a vein in your arm). In most cases, your healthcare provider will likely recommend that you continue taking traditional asthma medications alongside biologics. There are four FDA-approved biologic therapies for treating eos asthma, including: Fasenra (benralizumab): Prevents inflammatory cytokine interleukin-5 from activating eosinophils to reduce eosinophil counts and airway inflammationNucala (mepolizumab): Binds to interleukin-5 to decrease eosinophil counts in your blood and reduce airway inflammationCinqair (reslizumab): Lowers eosinophil counts in the blood and reduces airway inflammation by binding to interleukin-5 to control eosinophil productionDupixent (dupilumab): Binds to inflammatory cytokine interleukin-4 receptors to reduce airway inflammation How To Prevent Eosinophilic Asthma While there is no known way to prevent eosinophilic asthma from developing, several strategies can help reduce the frequency and severity of symptoms and asthma attacks. These include the following: Avoid triggers: Identify and avoid triggers that worsen your asthma symptoms. It may help to keep a symptom journal and write down your activities, foods you eat, and other potential environmental triggers. Common triggers include dust mites, pollen, cigarette smoke, strenuous exercise, and emotional stress. Follow your treatment plan: Take your asthma medications as prescribed and maintain regular follow-up appointments with your healthcare provider to ensure your medications are working and your eos asthma is well-controlled. Track your asthma: Use a peak flow monitor (a tool that measures how well air moves in and out of your lungs) to identify changes in your breathing before asthma symptoms appear. Using a peak flow monitor daily can help monitor treatment effectiveness, track changes in your breathing over time, and prevent asthma attacks. Related Conditions People with eosinophilic asthma often have other conditions that develop in response to overactive immune responses or high eosinophil counts. These include: Chronic rhinosinusitis with nasal polyps: Up to 60% of people with eos asthma have chronic rhinosinusitis with nasal polyps. Chronic sinus inflammation and polyps (soft growths) in the nasal passages cause a stuffy or runny nose, decreased sense of smell, facial pressure or pain, headaches, pain in the upper teeth, and snoring. Allergic rhinitis: Also known as hay fever, allergic rhinitis is inflammation of the nasal passages in response to allergen exposure. Many people with eos asthma also have allergic rhinitis, as both conditions involve an overactive immune response and airway inflammation. Eosinophilic esophagitis: A chronic inflammatory condition that develops when eosinophils inflame and irritate the esophagus, leading to symptoms like difficulty swallowing, heartburn, acid reflux, and chest pain. Living With Eosinophilic Asthma It can be challenging to live with eosinophilic asthma. When your symptoms are poorly controlled, you may have trouble participating in your daily activities, including work, school, and hobbies. Fortunately, leading a fulfilling, active life with the right treatments and support is possible with eos asthma. Adhering to your treatment plan and close communication with your healthcare provider is the best way to keep your asthma well-controlled. Seeking support from healthcare providers, support groups, and loved ones can also provide valuable emotional and practical support. Frequently Asked Questions What foods should I avoid with eosinophilic asthma? Research shows that a diet high in fruits, vegetables, whole grains, and healthy fats can reduce eosinophilic airway inflammation and help prevent worsening symptoms. A high-fat, low-fiber diet may increase eosinophilic inflammation in the airways. What is the difference between eosinophilic asthma and regular asthma? Eosinophilic asthma is a subtype of asthma in which high amounts of eosinophils (inflammatory white blood cells) cause airway inflammation. In other types of asthma, different inflammatory cells trigger airway inflammation.Eosinophilic asthma is a more severe subtype of asthma that does not always respond to traditional asthma medications and requires more targeted therapies to reduce eosinophil counts and airway inflammation. How rare is eosinophilic asthma? Approximately 25 million people in the United States live with asthma, and about 2.5 million live with severe asthma. According to the Global Initiative for Asthma (GINA), approximately 50% of people with severe asthma have eosinophilic asthma. Learn More: What Is Severe Asthma? Edited by Sukhman Rekhi Sukhman Rekhi Sukhman is a former editor at Health. learn more Was this page helpful? Thanks for your feedback! Tell us why! Other Submit 36 Sources Health.com uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. EOS Asthma Toolkit. About eosinophilic asthma. National Cancer Institute. Eosinophils. Wen Y, Wang D, Zhou M, Zhou Y, Guo Y, Chen W. Potential effects of lung function reduction on health-related quality of life. Int J Environ Res Public Health. 2019;16(2):260. doi:10.3390/ijerph16020260 Sedaghat AR. Chronic rhinosinusitis. Am Fam Physician. 2017;96(8):500-506. Global Allergy & Airways Patient Platform. Asthma at night: Causes, symptoms, treatment, and more information. Franceschi E, Drick N, Fuge J, et al. The impact of anti-eosinophilic therapy on exercise capacity and inspiratory muscle strength in patients with severe asthma. ERJ Open Res. 2023;9(2):00341-2022. doi:10.1183/23120541.00341-2022 Sharma S, Tasnim N, Agadi K, Asfeen U, Kanda J. Vulnerability for respiratory infections in asthma patients: A systematic review. Cureus. 2022;14(9):e28839. doi:10.7759/cureus.28839 American Academy of Pediatrics. Asthma attack. Gutiérrez-Albaladejo N, López-de-Andrés A, Cuadrado-Corrales N, et al. Asthma is associated with back pain and migraine-results of population-based case-control study. J Clin Med. 2023;12(22):7107. doi:10.3390/jcm12227107 Asthma & Allergy Network. Asthma attack. Merck Manual: Professional Version. Eosinophil function and production. Shen Y, Huang S, Kang J, et al. Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition). Int J Chron Obstruct Pulmon Dis. 2018;13:399-407. doi:10.2147/COPD.S144312 Hussain M, Liu G. Eosinophilic asthma: Pathophysiology and therapeutic horizons. Cells. 2024;13(5):384. doi:10.3390/cells13050384 El-Husseini ZW, Vonk JM, van den Berge M, Gosens R, Koppelman GH. Association of asthma genetic variants with asthma-associated traits reveals molecular pathways of eosinophilic asthma. Clin Transl Allergy. 2023;13(4):e12239. doi:10.1002/clt2.12239 Pelaia C, Paoletti G, Puggioni F, et al. Interleukin-5 in the pathophysiology of severe asthma. Front Physiol. 2019;10:1514. doi:10.3389/fphys.2019.01514 Centers for Disease Control and Prevention. Common asthma triggers. Asthma and Allergy Foundation of America. Understanding eosinophilic asthma. Asthma and Allergy Foundation of America. Emotions, stress, and depression. Klein DK, Silberbrandt A, Frøssing L, et al. Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma. Eur Respir J. 2022;60(4):2102446. doi:10.1183/13993003.02446-2021 EOS Asthma Toolkit. Eosinophilic asthma diagnosis and treatment. Chipps BE, Jarjour N, Calhoun WJ, et al. A Comprehensive Analysis of the Stability of Blood Eosinophil Levels. Ann Am Thorac Soc. 2021;18(12):1978-1987. doi:10.1513/AnnalsATS.202010-1249OC Goncalves B, Eze UA. Sputum induction and its diagnostic applications in inflammatory airway disorders: a review. Front Allergy. 2023;4:1282782. doi:10.3389/falgy.2023.1282782 American Academy of Allergy, Asthma & Immunology. Beta2-agonists defined. MedlinePlus. Benrumazilab injection. MedlinePlus. Mepolizumab injection. MedlinePlus. Reslizumab injection. MedlinePlus. Dupilumab injection. Asthma and Allergy Foundation of America. Preventing asthma. Asthma and Allergy Foundation of America. Peak flow meters. Bakakos A, Schleich F, Bakakos P. Biological therapy of severe asthma and nasal polyps. J Pers Med. 2022;12(6):976. doi:10.3390/jpm12060976 American College of Allergy, Asthma & Immunology. Chronic rhinosinusitis and nasal polyps. Rebrova S, Emelyanov A, Sergeeva G, Korneenkov A. Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis. Allergy Asthma Proc. 2024;45(1):e9-e13. doi:10.2500/aap.2024.45.230077 MedlinePlus. Eosinophilic esophagitis. McDiarmid KP, Wood LG, Upham JW, et al. The impact of meal dietary inflammatory index on exercise-induced changes in airway inflammation in adults with asthma. Nutrients. 2022;14(20):4392. doi:10.3390/nu14204392 Carr TF, Zeki AA, Kraft M. Eosinophilic and noneosinophilic asthma. Am J Respir Crit Care Med. 2018;197(1):22-37. doi:10.1164/rccm.201611-2232PP Global Initiative for Asthma. Global strategy for asthma management and prevention.